突发性耳聋合并代谢综合征患者临床治疗效果的影响因素分析
DOI:
作者:
作者单位:

广州医科大学附属第三医院

作者简介:

通讯作者:

基金项目:


Analysis of influencing factors of clinical treatment effect in patients with sudden sensorineural hearing loss complicated with metabolic syndrome
Author:
Affiliation:

The Third Affiliated Hospital of Guangzhou Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨突发性耳聋合并代谢综合征患者的临床特征及各相关因素对预后的影响。方法 回顾性分析2019年4月-2021年8月我院耳鼻喉科收治的98例突发性耳聋合并代谢综合征患者的临床资料,其中单耳86例,双耳6例,共104耳,根据治疗效果分为无效组62耳,有效组42耳,分析突发性耳聋合并代谢综合征患者临床治疗效果的影响因素。结果 98例(104耳)突发性耳聋合并代谢综合征患者治疗总有效率40.38%,其中无效62例,有效29例,显效4例,痊愈9例;治疗无效组发病天数≥7d、伴发眩晕、未使用巴曲酶比例高于治疗有效组(P<0.05),听力损失低频型患者预后较好(P<0.05);两组年龄、性别、耳侧、听力损失分型(高频型、平坦型、全聋型)、凝血酶原时间、部分凝血活酶时间、纤维蛋白原、凝血酶时间、血小板计数相比无明显差异(P>0.05)。Logistic回归分析显示,发病天数≥7d、伴发眩晕是影响突发性耳聋合并代谢综合征患者临床治疗效果的独立危险因素(P<0.05且OR>1)。结论 突发性耳聋合并代谢综合征患者治疗有效率偏低,其中发病天数≥7d、伴发眩晕是影响临床治疗效果的独立危险因素,临床治疗时应予以重视。

    Abstract:

    Objective to investigate the clinical characteristics of patients with sudden sensorineural hearing loss complicated with metabolic syndrome and the influence of various related factors on the prognosis.Methods:98 cases of sudden sensorineural hearing loss patients complicated with metabolic syndrome and admitted to our hospital"s otolaryngology department from April 2019 to August 2021 Clinical data were retrospectively analyzed ,including 86 cases in one ear and 6 cases in both ears, a total of 104 ears. According to the treatment effect, they were classified as invalid group 62 ears, effective group 42 ears to analyze the influencing factors of clinical treatment effect in patients with sudden sensorineural hearing loss and metabolic syndrome.Result:98 cases (104 ears) of patients with sudden sensorineural hearing loss complicated with metabolic syndrome had a total effective rate of 40.38%, of which 62 were ineffective cases, 29 cases were effective, 4 cases were markedly effective, and 9 cases were cured; in the treatment-ineffective group, as for the number of days of onset was ≥7 days, accompanied by dizziness, and no batroxobin was used ,the ratio was higher than the treatment effective group (P<0.05), and the prognosis of low frequency hearing loss type was better (P<0.05). In two groups , there was no significant difference in age, gender, ear side, hearing loss type (high frequency type, flat type, profound type), prothrombin time,active partial thromboplastin time,fibrinogen, thrombin time, and platelet count (P>0.05). Logistic regression analysis shows that days of onset which were≥7 days and being accompanied by dizziness were independent risk factors affecting the clinical treatment of patients with sudden sensorineural hearing loss complicated with metabolic syndrome (P<0.05 and OR>1). Conclusion The effective rate of treatment for patients with sudden sensorineural hearing loss complicated with metabolic syndrome is low.And days of onset which are≥7 days and being accompanied by dizziness are independent risk factors affecting the clinical therapic effects,which should be paid attention.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2021-12-29
  • 最后修改日期:2022-01-24
  • 录用日期:2022-01-28
  • 在线发布日期:
新投稿系统运行通知

作者投稿请直接点击左侧“作者登录”,请不要进入旧版入口。如登录或投稿中遇到任何问题,请联系电话13311390237。谢谢!

关闭